Lihong Wu

机构：Sun Yat-sen University, Sir Run Run Shaw Hospital, Taiwan Futures Exchange (Taiwan), The First Affiliated Hospital, Sun Yat-sen University, Zhejiang University · ORCID：0000-0002-1903-6981

发表论文 89 篇 · 总被引 2536 次 · h-index 26

代表论文

• Catalytic Intermolecular Asymmetric [2π + 2σ] Cycloadditions of Bicyclo[1.1.0]butanes: Practical Synthesis of Enantioenriched Highly Substituted Bicyclo[2.1.1]hexanes (2024 · Journal of the American Chemical Society · 被引 68)
• Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese (2023 · Cell Reports Medicine · 被引 23)
• LBA6 PACIFIC-5: A phase III study of consolidation durvalumab (D) in patients (pts) with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy (cCRT or sCRT) (2024 · Annals of Oncology · 被引 9)
• External validation of a model for selecting day 3 embryos for transfer based upon deep learning and time-lapse imaging (2023 · Reproductive BioMedicine Online · 被引 7)
• Gender differences of the association between work-related stressors and mental health among Chinese medical professionals: a nationwide cross-sectional study (2025 · Frontiers in Public Health · 被引 5)
• Dual mode of action herbicide rimisoxafen targets both phytoene desaturase and solanesyl diphosphate synthase (2025 · Pest Management Science · 被引 4)